151 related articles for article (PubMed ID: 21491170)
1. The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer.
Jung S; Yi L; Kim J; Jeong D; Oh T; Kim CH; Kim CJ; Shin J; An S; Lee MS
Mol Cells; 2011 May; 31(5):405-11. PubMed ID: 21491170
[TBL] [Abstract][Full Text] [Related]
2. The role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancer.
Jung S; Jeong D; Kim J; Yi L; Koo K; Lee J; Lee SD; Park JW; Chang B; Kim CH; Kim CJ; Lee MS
Oncol Rep; 2010 Jun; 23(6):1675-82. PubMed ID: 20428825
[TBL] [Abstract][Full Text] [Related]
3. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer.
Jung S; Jeong D; Kim J; Yi L; Koo K; Lee J; Kim CJ; Kim CH; An S; Yang Y; Lim JS; Kim KI; Lee MS
Int J Oncol; 2011 Mar; 38(3):859-69. PubMed ID: 21240459
[TBL] [Abstract][Full Text] [Related]
5. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
7. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening.
Dong S; Lu Q; Xu P; Chen L; Duan X; Mao Z; Zhang B; Sui L; Wang Y; Yu W
Clin Transl Med; 2021 Jun; 11(6):e457. PubMed ID: 34185407
[No Abstract] [Full Text] [Related]
9. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
[TBL] [Abstract][Full Text] [Related]
11. [Association of promoter methylation of ERp57 gene with the pathogenesis of cervical lesions in Uighur women].
Abdula M; Abudulajiang G; Amiduo R; Abudala A; Hasim A
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):600-3. PubMed ID: 24314218
[TBL] [Abstract][Full Text] [Related]
12. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
[TBL] [Abstract][Full Text] [Related]
13. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia.
Kang S; Kim J; Kim HB; Shim JW; Nam E; Kim SH; Ahn HJ; Choi YP; Ding B; Song K; Cho NH
Diagn Mol Pathol; 2006 Jun; 15(2):74-82. PubMed ID: 16778587
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.
Dong Y; Tan Q; Tao L; Pan X; Pang L; Liang W; Liu W; Zhang W; Li F; Jia W
Int J Clin Exp Pathol; 2015; 8(2):1844-54. PubMed ID: 25973077
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
16. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.
Kitkumthorn N; Yanatatsanajit P; Kiatpongsan S; Phokaew C; Triratanachat S; Trivijitsilp P; Termrungruanglert W; Tresukosol D; Niruthisard S; Mutirangura A
BMC Cancer; 2006 Mar; 6():55. PubMed ID: 16524460
[TBL] [Abstract][Full Text] [Related]
17. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
18. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women].
Aikuer G; Jiao Z; Wu XC; Ma JQ; Abudla A; Hasim A
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):438-42. PubMed ID: 22932452
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
